1、 l : : $Te 31V Y% )f b!Tb * : RFNQ RHMNJ % XNSF HTR bc8 c $ o )Fsf Z *8 f ,n 3 K3 K1 “5 00 $ o ) m9 00 ) . ) 00% ) 4sr F ) e y7rf $ o ) AF1b 7? $ o )G f a8T f a 73FHHNSJ (FUXZQFW UTQXFHHMFWNIJX +NGWTSJHYNS : GNSINSL UWTYJNSX 73 :2= : 2oMs0 tb ,FRUKJWBlM: 9889 f Et kcc 3 fZ M 5WTL NS 2NHWTGNTQ .RRZST
2、Q )JH ;TQ 3T QF 0 :5.93 aMs0 bC 7FHHNSJ UTYJSYNFQ TK UTQ :FHHNSJ :B +FYYTR FSS NT : JUWJXXJIcc 3 fZ M 5WTL NS 2NHWTGNTQ .RRZSTQ )JH ;TQ 3T FSYNLJS / B 8HNJSHJ :B 7JSSJWRFQR FHHNSJ :B 2FRT JY FQ 7JLZQFYNTSX TK nuy| :p|pp nr UFYMTLJSJXNX NF YFWLJY TK 73TS LFGFNS FHHNSJ FXXJRGQ KWTR XZWKFHJUWTYJNSX TK
3、nuy|p|pp nr / B 53FHHNSJ :B 8MPWJYF 1 9FQGTY , )NFWWF 28 JY FQ .RRZSJ WJXUTSXJ YT F)3FHHNSJ :B ,FZIWJFZ 2( 1FHFXXJ 5 9FQGTY , 5WTYJHYNJ NRRZSJ WJ :XUTSXJX YT F RZQYN : LJSJ )3FHHNSJ :B; B?C + $ o )3TQ 3T 金黄色葡萄球菌组分疫苗研究进展作者： 谢茂超， 熊慧玲(综述)， 张雪梅(审校)， XIE Mao-chao， XIONG Hui-ling， ZHANGXue-mei作者单位： 成都生物制品
4、研究所有限责任公司,成都,610063刊名： 微生物学免疫学进展英文刊名： Progress in Microbiology and Immunology年，卷(期)： 2013(6)参考文献(52条)1.肖永红;沈萍;魏泽庆 2011 年度 Mohnarin 全国细菌耐药监测 2012(22)2.Mckenney D;Pouliot K;Wang Y Vaccine potential of poly-1-6-D-N-succinylglucosamine,animmunoprotective surface pol-ysaccharide of Staphylococcus aureus
5、and Staphylococcus epidermi-dis2000(1/2)3.Ayliffe GA The progressive intercontinental spread of methicillin-resistant Staphylococcus aureus1997(Suppl 1)4.徐英春;王贺;孙宏莉 细菌耐药监测让我们走近临床期刊论文-H中华检验医学杂志 2007(05)5.Lee JC An experimental vaccine that targets staphylococcal viru-lence 1998(12)6.Benquan W;Yingchu
6、n T;Kouxing Z Staphylococcus het-erogeneously resistant to vancomycin in Chinaand antimicrobiol activities of imipenem and vancomycin in combination against it 2002(03)7.Centers for Disease Control and Prevention (CDC) Staphylococ-cus aureus resistant to vancomycin-United States,2002 2002(26)8.Watso
7、n DL;Kennedy JW Immunisation against experimental Staphylococcal mastitis in sheep effect ofchallenge with a heterolo-gous of Staphylococcus aureus 1981(07)9.Watson DC Vaccination against experimental staphylococcal mas-titis in dairy heiters 1992(03)10.Tollersrud T;Zernichow L;Anderson SR Staphyloc
8、occus aureus capsular polysaccharide type 5conjugate and whole cell vaccine stimulate antibody responses in cattle 2001(28/29)11.Sompolinsky D;Samra Z;Karakawa WW Encapsulation and capsular types in isolates of Staphylococcusaureus from dif-ferent sources and relationship to phage types 1985(05)12.F
9、attom A;Fuller S;Propst M Safety and immunogenicity of a booster dose of Staphylococcus aureustype 5 and type 8 cap-sular polysaccharides conjugate vaccine(StaphVAX) in hemodi-alysis patients2004(05)13.Fournier JM;Hannon K;Moreau M Isolation of type 5 capsular polysaccharide from Staphylococcusaureu
10、s 1987(05)14.Gilbert FB;Poutrel B;Sutra L Immunogenicity in cows of Staph-ylococcus aureus type 5 capsularpolysaccharide-ovalbumin conju-gate 1994(04)15.Sau S;Bhasin N;Wann ER The Staphylococcus aureus al-lelic genetic loci for serotype 5 and 8capsule expression contain the type-specific genes flank
11、ed by common genes 1997(07)16.Fattom AI;Sarwar J;Basham L Antigenic determinants of Staphylococcus aureus type 5 and type 8capsular polysaccharides vaccines 1998(10)17.Moreau M;Richards JC;Fournier JM Structure of the type 5 capsular polysaccharide ofStaphylococcus aureus 1990(02)18.Fattom A;Horwith
12、 G;Fuller S Development of Staph-VAX, a polysaccharides conjugate vaccine againstS.aureus in-fection：from the lab bench to phase III clinical trials 2004(07)19.Fattom A;Shiloach J;Bryla D Comparative immunoge-nicity of conjugates composed of Staphylococcusaureus type 8 capsular polysaccharide bound
13、to carrier proteins by adipic acid dihydrazide or N-succinimidyl-3-(2-pyridyldithio) propionate 1992(02)20.Fattom A;Li X;Cho YH Effect of conjugation methodol-ogy,carrier protein,and adjuvants on theimmune response to Staphylococcus aureus capsular polysaccharides 1995(14)21.Fattom A;Schneerson R;Sz
14、u SC Synthesis and immuno-logic properties in mice of vaccines composedof Staphylococcus aureus type 5 and type 8 capsular polysaccharides conjugated to Pseudomonasaeruginosa exotoxin A 1990(07)22.Robbins JB;Schneerson R;Vann WF Prevention of sys-temic infections caused by group BStreptococcus and S
15、taphylococ-cus aureus by multivalent polysaccharide-protein conjugate vac-cines199523.Brien CN;Guidry AJ;Fattom A Production of anti-bodies to Staphylococcus aureus serotypes 5,8 and336 using poly (DL-lactide-co-glycolide) microspheres 2000(08)24.Mckenney D;Pouliot KL;Wang Y Broadly protective vacci
16、ne for Staphylococcus aureus based on an inVivo-expressed antigen 1999(5419)25.Rennermalm A;Li YH;Bohaufs L Antibodies against a truncated Staphylococcus aureus fibronectin-binding protein pro-tect against dissemination of infection in the rat 2001(25/26)26.Mamo W;Jonsson P;Flock JI Vaccination agai
17、nst Staphy-lococcus aureus mastitis:immunologicalresponse of mice vacci-nated with fibronectin-binding protein (FnBP-A) to challenge with S.aureus1994(11)27.Brennan FR;Jones TD;Longstaff M Immunogenicity of peptides derived from a fibronectin-bindingprotein of S.aureus expressed on two different pla
18、nt viruses 1999(15/16)28.Casolini F;Visai L;Joh D Antibody response to fibronec-tin-bind ingadhesin FnbpA in patients withStaphylococcus aureus infections 1998(11)29.Flock JI;Hienz SA;Heimdahl A Reconsideration of the role of fibronectin binding in endocarditiscaused by Staphylococ-cus aureus 1996(0
19、5)30.Jonsson K;Signas C;Muller HP Two different genes en-code fibronection binding proteins inStaphylococcus aureus.The complete nucleotide sequence and characterization of the second gene1991(03)31.Signas C;Raucci G;Jonsson K Nucleotide sequence of the gene for a fibronection binding proteinfrom St
20、aphylococcus aureus:Use of this peptide sequence in the synthesis of biologi-cally activepeptides 1989(02)32.Nilsson IM;Verdrengh M;Ulrich RG Protection against Staphylococcus aureus sepsis by vaccinationwith recombinant Staphylococcal enterotoxin A devoid of superantigenicity 1999(04)33.Stiles BG;G
21、arza AR;Ulrich RG Mucosal vaccination with recombinantly attenuated Staphylococcalenterotoxin B and protection in a Murine Model 2001(04)34.Gampfer J;Thon V;Gulle H Double mutant and formal-dehyde inactivated TSST-1 as vaccine candidatesfor TSST-1-in-duced toxic shock syndrome 2002(9/10)35.Schliever
22、t PM;Shands KN;Dan BB Identification and characterization of an exotoxin fromStaphylococcus aureus associ-ated with toxic-shock syndrome 1981(04)36.Bonventre PF;Weckbach L;Staneck J Production of Staphylococcal enterotoxin F and pyrogenicexotoxin C by Staph-ylococcus aureus isolates from toxic shock
23、 syndrome-associated sources 1983(03)37.Earhart CA;Mitchell DT;Murray DL Structures of five mutants of toxic shock syndrome toxin-1 withreduced biological activity 1998(20)38.Herbelin C;Poutrel B;Gilbert FB Immune recruitmentand bactericidal activity of neutrophils inmilk of cows vaccinated with Sta
24、phylococcal -toxin 1997(09)39.Hume EBH;Dajcs JJ;Moreau JM Immunization with al-pha-toxin toxoid protects the cornea againsttissue damage during experimental Staphylococcus aureus keratitis 2000(10)40.Bubeck Wardenburg J;Schneewind O Vaccine protection a-gainst Staphylococcus aureus pneumonia2008(02)
25、41.Balaban N;Goldkorn T;Gov Y Regulations of Staphylo-coccus aureus pathogenesis via target ofRNAIII-activating protein (TRAP) 2001(04)42.Abdelnour A;Arvidson S;Bremell T The accessory gene regulator(agr) controls Staphylococcus aureusvirulence in a mu-rine arthritis model 1993(09)43.Novick RP;Ross
26、HF;Projan SJ Synthesis of Staphylo-coccal virulence factors is controlled by aregulatory RNA mole-cule 1993(10)44.Novick RP;Projan SJ;Kornblum J The agr P2 operon:an autocatalytic sensory transduction system inStaphylococcus aureus 1995(04)45.Yan QX;Yeamann MR;Bayer AS New approaches to the pre-vent
27、ion and treatment of severe S.aureusinfections 2000(08)46.Moerfeldt E;Taylor D;Von gabain A Activation of alpha-toxin translation in Staphylococcus aureusby the trans-encoded antisence RNA,RNAIII 1995(18)47.Yukiko K;Jones S;Bae T Vaccine assembly from surface proteins of Staphylococcus aureus 2006(4
28、5)48.Nour El-Din ANM;Shkreta L;Talbot BG DNA immuniza-tion of dairy cows with the clumping factor A ofStaphylococcus aureus 2006(12)49.Shkreta L;Talbot BG;Diarra MS Immune response to a DNA/protein vaccination strategy againstStaphylococcus aureus induced mastitis in dairy cows 2004(01)50.Gaudreau M
29、C;Lacasse P;Talbot BG Protective immune re-sponses to a multi-gene DNA vaccine againstStaphylococcus au-reuss 2007(05)51.陈宇光;倪继祖;沈彦萍 金黄色葡萄球菌DNA疫苗pcDNA3.1 (+)-Minigene及其制备方法 200752.David MZ;Daum RS Community-associated methicillin-resistant Staphylococcus aureus:epidemiologyand clinical consequences of an emerging epidemic 2010(03)本文链接：http:/
